Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate-specific Membrane Antigen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06209853
What this trial is testing

Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient

Who this might be right for
Prostatic Neoplasms
Assiut University 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07387510
What this trial is testing

PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows

Who this might be right for
Prostate Cancer Patients Undergoing Radical Prostatectomy
Haitao Niu, MD 27
Not applicableUnknownNCT03313726
What this trial is testing

The Effect of ADT on PSMA-PET.

Who this might be right for
Prostate Cancer
Turku University Hospital 30
Early research (Phase 1)Study completedNCT06101927
What this trial is testing

Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413

Who this might be right for
Prostate Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Early research (Phase 1)Study completedNCT02048150
What this trial is testing

Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage IIB Prostate CancerStage III Prostate Cancer+1 more
City of Hope Medical Center 7
Early research (Phase 1)Study completedNCT03995888
What this trial is testing

Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 24
Early research (Phase 1)Study completedNCT01414296
What this trial is testing

Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 10
Not applicableWithdrawnNCT01173146
What this trial is testing

Imaging of Residual Tumor During Prostatectomy

Who this might be right for
Prostate Cancer
Spectros Corporation
Large-scale testing (Phase 3)Looking for participantsNCT07426094
What this trial is testing

PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer

Who this might be right for
Prostate CancerBrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 600
Testing effectiveness (Phase 2)Looking for participantsNCT05761366
What this trial is testing

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

Who this might be right for
Malignancy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 400
Early research (Phase 1)Study completedNCT05441501
What this trial is testing

JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 39
Early research (Phase 1)Ended earlyNCT04227275
What this trial is testing

CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 16
Testing effectiveness (Phase 2)Looking for participantsNCT07590934
What this trial is testing

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 152
Not applicableUnknownNCT05448404
What this trial is testing

A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma

Who this might be right for
Multiple Myeloma
First Hospital of China Medical University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06004661
What this trial is testing

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 23
Testing effectiveness (Phase 2)Study completedNCT05114746
What this trial is testing

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 94
Testing effectiveness (Phase 2)Looking for participantsNCT07258407
What this trial is testing

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostatic Cancer
T.O.A.D. Oncology SA 180
Not applicableUnknownNCT04588454
What this trial is testing

18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Radboud University Medical Center 5
Testing effectiveness (Phase 2)Looking for participantsNCT04573231
What this trial is testing

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer
University of Wisconsin, Madison 13
Early research (Phase 1)Study completedNCT01414283
What this trial is testing

Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 52
Next Page